Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2022-12-01 13:35 Tx date 2022-11-30 |
$CURE
Biocure Technology Inc. |
Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-471.00
-47,100 vol $0.01 each |
104,181 | |
Filed 2022-06-08 23:52 Tx date 2021-02-16 |
$CURE
Biocure Technology Inc. |
Joh, Danny
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+250,000 vol $0.30 each |
250,000 | |
Filed 2022-06-08 23:39 Tx date 2019-03-13 |
$CURE
Biocure Technology Inc. |
Joh, Danny
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-08-27 15:51 Tx date 2021-07-21 |
$CURE
Biocure Technology Inc. |
Cochlovius, Bjorn
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+250,000 vol $0.30 each |
250,000 | |
Filed 2021-08-27 15:44 Tx date 2021-08-26 |
$CURE
Biocure Technology Inc. |
Cochlovius, Bjorn
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-07-22 19:10 Tx date 2021-07-21 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
850,000 | |
Filed 2021-07-20 13:47 Tx date 2020-10-15 |
$CURE
Biocure Technology Inc. |
Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$7,560
+36,000 vol $0.21 each |
36,000 | |
Filed 2021-07-20 13:42 Tx date 2018-03-01 |
$CURE
Biocure Technology Inc. |
Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-07-16 18:30 Tx date 2020-10-15 |
$CURE
Biocure Technology Inc. |
Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$5,040
+36,000 vol $0.14 each |
115,281 | |
Filed 2021-07-16 18:28 Tx date 2020-01-02 |
$CURE
Biocure Technology Inc. |
Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$14,999
+68,181 vol $0.22 each |
79,281 | |
Filed 2021-07-16 18:12 Tx date 2021-02-16 |
$CURE
Biocure Technology Inc. |
Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$135,000
+450,000 vol $0.30 each |
450,000 | |
Filed 2021-07-16 18:11 Tx date 2021-01-01 |
$CURE
Biocure Technology Inc. |
Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-114,000
-300,000 vol $0.38 each |
0 | |
Filed 2021-07-16 18:09 Tx date 2021-02-16 |
$CURE
Biocure Technology Inc. |
Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-114,000
-300,000 vol $0.38 each |
||
Filed 2021-03-31 01:27 Tx date 2021-02-11 |
$CURE
Biocure Technology Inc. |
Ünal, Berkan
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
112,000 | ||
Filed 2021-03-31 01:19 Tx date 2021-02-16 |
$CURE
Biocure Technology Inc. |
Ünal, Berkan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+250,000 vol $0.30 each |
350,000 | |
Filed 2021-03-31 01:16 Tx date 2021-02-11 |
$CURE
Biocure Technology Inc. |
Ünal, Berkan
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
Filed 2021-03-31 01:10 Tx date 2021-02-11 |
$CURE
Biocure Technology Inc. |
Ünal, Berkan
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
112,000 | ||
Filed 2021-02-18 19:12 Tx date 2020-10-16 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Warrants
53 - Grant of warrants
|
$7,526
+35,839 vol $0.21 each |
35,839 | |
Filed 2021-02-18 18:47 Tx date 2017-06-21 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-02-18 17:40 Tx date 2020-10-16 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
53 - Grant of warrants
|
$7,526
+35,839 vol $0.21 each |
||
Filed 2020-10-21 13:59 Tx date 2020-10-16 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
53 - Grant of warrants
|
$7,526
+35,839 vol $0.21 each |
||
Filed 2021-02-17 21:03 Tx date 2021-02-16 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$300,000
+1,000,000 vol $0.30 each |
1,035,839 | |
Filed 2021-02-17 21:00 Tx date 2021-01-04 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
-900,000 vol |
35,839 | |
Filed 2021-02-17 15:38 Tx date 2021-02-16 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$180,000
+600,000 vol $0.30 each |
600,000 | |
Filed 2021-02-17 15:34 Tx date 2021-01-04 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-480,000 vol |
0 | |
Filed 2020-10-21 13:59 Tx date 2020-10-16 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
53 - Grant of warrants
|
$7,526
+35,839 vol $0.21 each |
935,839 | |
Filed 2020-10-21 13:46 Tx date 2020-10-16 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$5,017
+35,839 vol $0.14 each |
27,317,506 | |
Filed 2020-10-21 09:22 Tx date 2020-10-16 |
$CURE
Biocure Technology Inc. |
Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$5,040
+36,000 vol $0.14 each |
47,100 | |
Filed 2020-10-20 13:16 Tx date 2020-10-16 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$5,017
+35,839 vol $0.14 each |
||
Filed 2020-10-20 15:02 Tx date 2020-10-16 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Holder: JNS Global Energy Inc. (Indirect Ownership)
|
Options
53 - Grant of warrants
|
$7,560
+36,000 vol $0.21 each |
36,000 | |
Filed 2020-10-20 14:56 Tx date 2015-08-28 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Holder: JNS Global Energy Inc. (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-10-20 14:54 Tx date 2020-10-16 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Holder: JNS Global Energy Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$5,040
+36,000 vol $0.14 each |
104,181 | |
Filed 2020-10-20 14:47 Tx date 2020-10-16 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Holder: JNS Global Energy Inc. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$5,040
+36,000 vol $0.14 each |
||
Filed 2020-10-20 13:16 Tx date 2020-10-16 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$5,017
+35,839 vol $0.14 each |
27,317,506 | |
Filed 2020-10-14 16:16 Tx date 2019-03-08 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
-600,000 vol |
0 | |
Filed 2020-10-14 15:56 Tx date 2019-03-08 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
+600,000 vol |
||
Filed 2020-10-14 15:56 Tx date 2019-03-08 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
52 - Expiration of options
|
+600,000 vol |
1,200,000 | |
Filed 2020-10-14 15:48 Tx date 2019-04-12 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+480,000 vol |
480,000 | |
Filed 2020-10-14 15:43 Tx date 2019-03-08 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-240,000 vol |
0 | |
Filed 2020-10-14 15:38 Tx date 2019-04-12 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+900,000 vol |
2,100,000 | |
Filed 2020-01-06 00:50 Tx date 2020-01-03 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Holder: JNS Global Energy Inc. (Indirect Ownership)
|
Common Shares
46 - Compensation for services
|
$14,999
+68,181 vol $0.22 each |
68,181 | |
Filed 2020-01-06 00:47 Tx date 2015-08-28 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Holder: JNS Global Energy Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-11-01 15:30 Tx date 2019-10-30 |
$CURE
Biocure Technology Inc. |
Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-4,773
-11,100 vol $0.43 each |
11,100 | |
Filed 2019-04-16 13:09 Tx date 2019-03-07 |
$CURE
Biocure Technology Inc. |
Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$136,250
+125,000 vol $1.09 each |
||
Filed 2019-04-16 13:08 Tx date 2018-03-01 |
$CURE
Biocure Technology Inc. |
Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$127,500
+125,000 vol $1.02 each |
||
Filed 2019-04-16 13:07 Tx date 2019-03-07 |
$CURE
Biocure Technology Inc. |
Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$136,250
+125,000 vol $1.09 each |
||
Filed 2019-04-16 13:06 Tx date 2019-04-12 |
$CURE
Biocure Technology Inc. |
Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$114,000
+300,000 vol $0.38 each |
300,000 | |
Filed 2018-03-27 20:25 Tx date 2018-03-01 |
$CURE
Biocure Technology Inc. |
Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$127,500
+125,000 vol $1.02 each |
||
Filed 2019-03-15 Tx date 2019-03-13 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-3,000 vol |
196,723 | |
Filed 2018-12-05 Tx date 2018-12-01 |
$CURE
Biocure Technology Inc. |
Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$9,990
+22,200 vol $0.45 each |
22,200 | |
Filed 2018-12-05 Tx date 2018-03-01 |
$CURE
Biocure Technology Inc. |
Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-12-05 Tx date 2018-12-01 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-22,200 vol |
199,723 | |
Filed 2018-11-26 Tx date 2018-11-24 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-127,800 vol |
240,000 | |
Filed 2018-11-26 Tx date 2018-11-23 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$28,880
+72,200 vol $0.40 each |
221,923 | |
Filed 2018-11-26 Tx date 2018-11-23 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-72,200 vol |
367,800 | |
Filed 2018-09-25 Tx date 2018-09-24 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-4,000 vol |
149,723 | |
Filed 2018-09-19 Tx date 2018-04-01 |
$CURE
Biocure Technology Inc. |
Nonni, Mark
1 - Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
264,000 | ||
Filed 2018-09-07 Tx date 2018-08-27 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,000 vol |
||
Filed 2018-09-07 Tx date 2018-08-27 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,000 vol |
162,223 | |
Filed 2018-09-07 Tx date 2018-09-07 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-8,500 vol |
153,723 | |
Filed 2018-08-29 Tx date 2018-08-27 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,000 vol |
162,223 | |
Filed 2018-08-24 Tx date 2018-08-23 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-6,500 vol |
165,723 | |
Filed 2018-08-24 Tx date 2018-08-24 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-1,500 vol |
164,223 | |
Filed 2018-08-14 Tx date 2018-08-13 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,500 vol |
172,223 | |
Filed 2018-08-10 Tx date 2018-08-09 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-500 vol |
189,223 | |
Filed 2018-08-10 Tx date 2018-08-08 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$32,000
+80,000 vol $0.40 each |
189,723 | |
Filed 2018-08-10 Tx date 2018-08-10 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-11,500 vol |
177,723 | |
Filed 2018-08-10 Tx date 2018-08-08 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-80,000 vol |
440,000 | |
Filed 2018-08-07 Tx date 2018-08-07 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-4,000 vol |
109,723 | |
Filed 2018-08-07 Tx date 2018-08-03 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-16,000 vol |
113,723 | |
Filed 2018-07-31 Tx date 2018-07-30 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-10,000 vol |
129,723 | |
Filed 2018-07-20 Tx date 2018-07-19 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-10,000 vol |
139,723 | |
Filed 2018-07-06 Tx date 2018-07-05 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-100,000 vol |
520,000 | |
Filed 2018-07-06 Tx date 2018-07-06 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
149,723 | |
Filed 2018-07-06 Tx date 2018-07-05 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$40,000
+100,000 vol $0.40 each |
154,723 | |
Filed 2018-07-05 Tx date 2018-07-05 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-15,000 vol |
54,723 | |
Filed 2018-07-03 Tx date 2018-07-03 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,800
-38,500 vol $0.80 each |
69,723 | |
Filed 2018-06-25 Tx date 2018-06-22 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,600
-2,000 vol $0.80 each |
108,223 | |
Filed 2018-06-19 Tx date 2018-06-15 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,600
-9,500 vol $0.80 each |
110,223 | |
Filed 2018-06-19 Tx date 2018-06-15 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,800
-8,500 vol $0.80 each |
||
Filed 2018-06-18 Tx date 2018-06-15 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,800
-8,500 vol $0.80 each |
111,223 | |
Filed 2018-04-16 Tx date 2018-04-11 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
600,000 | |
Filed 2018-04-16 Tx date 2018-04-11 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
||
Filed 2018-04-16 Tx date 2017-06-21 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-16 Tx date 2017-06-21 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-13 Tx date 2018-04-11 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$165,600
+240,000 vol $0.69 each |
||
Filed 2018-04-13 Tx date 2018-04-11 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+240,000 vol |
620,000 | |
Filed 2018-03-27 Tx date 2018-03-01 |
$CURE
Biocure Technology Inc. |
Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$127,500
+125,000 vol $1.02 each |
125,000 | |
Filed 2018-03-27 Tx date 2018-03-01 |
$CURE
Biocure Technology Inc. |
Lichtenwald, Konstantin
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-02-21 Tx date 2018-02-21 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-20,000
-50,000 vol $0.40 each |
380,000 | |
Filed 2018-02-21 Tx date 2018-02-21 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$20,000
+50,000 vol $0.40 each |
119,723 | |
Filed 2018-02-17 Tx date 2018-02-16 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-20,000
-50,000 vol $0.40 each |
430,000 | |
Filed 2018-02-17 Tx date 2017-11-24 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+480,000 vol |
480,000 | |
Filed 2018-02-17 Tx date 2017-11-24 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+480,000 vol |
||
Filed 2018-02-17 Tx date 2015-08-28 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-02-17 Tx date 2018-02-16 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$20,000
+50,000 vol $0.40 each |
69,723 | |
Filed 2018-02-07 Tx date 2018-02-06 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,500
-10,000 vol $1.55 each |
19,723 | |
Filed 2018-02-01 Tx date 2017-11-30 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-250,277 vol |
49,723 | |
Filed 2018-02-01 Tx date 2017-11-30 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-250,278 vol |
||
Filed 2018-02-01 Tx date 2018-02-01 |
$CURE
Biocure Technology Inc. |
Kim, Sang Goo
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-29,000
-20,000 vol $1.45 each |
29,723 | |
Filed 2017-11-28 Tx date 2017-11-24 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+25,090,272 vol |
27,281,667 | |
Filed 2017-11-28 Tx date 2017-11-24 |
$CURE
Biocure Technology Inc. |
LEE, SANG MOK
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-11,030,342 vol |
2,191,395 |